Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 13, 2019
Identification of novel glutathione conjugates of terbinafine in liver microsomes and hepatocytes across speciesAmol Patil, Mayurbhai Kathadbhai Ladumor, Shyam H Kamble, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 2, 2013
Characterization of recombinantly expressed rat and monkey intestinal alkaline phosphatases: in vitro studies and in vivo correlationsMurali Subramanian, Sundeep Paruchury, Shashyendra Singh Gautam, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 21, 2014
Role of hepatic blood flow and metabolism in the pharmacokinetics of ten drugs in lean, aged and obese ratsMurali Subramanian, Vishwanath Kurawattimath, Krishna Pocha, et al.Journal of Medicinal Chemistry|August 11, 2022
Improving Drug Delivery While Tailoring Prodrug Activation to Modulate Cmax and Cmin by Optimization of (Carbonyl)oxyalkyl Linker-Based Prodrugs of AtazanavirMurugaiah A M Subbaiah, Lakshumanan Subramani, Thangeswaran Ramar, et al.European Journal of Medicinal Chemistry|October 16, 2020
(Carbonyl)oxyalkyl linker-based amino acid prodrugs of the HIV-1 protease inhibitor atazanavir that enhance oral bioavailability and plasma trough concentrationMurugaiah A M Subbaiah, Thangeswaran Ramar, Lakshumanan Subramani, et al.The Journal of Pharmacology and Experimental Therapeutics|October 27, 2009
CYP2C9*1B promoter polymorphisms, in linkage with CYP2C19*2, affect phenytoin autoinduction of clearance and maintenance doseAmarjit S Chaudhry, Thomas J Urban, Jatinder K Lamba, et al.Journal of Medicinal Chemistry|April 26, 2018
Coupling of an Acyl Migration Prodrug Strategy with Bio-activation To Improve Oral Delivery of the HIV-1 Protease Inhibitor AtazanavirMurugaiah A M Subbaiah, Nicholas A Meanwell, John F Kadow, et al.Journal of Medicinal Chemistry|April 3, 2019
Design, Synthesis, and Pharmacokinetic Evaluation of Phosphate and Amino Acid Ester Prodrugs for Improving the Oral Bioavailability of the HIV-1 Protease Inhibitor AtazanavirMurugaiah A M Subbaiah, Sandhya Mandlekar, Sridhar Desikan, et al.ACS Medicinal Chemistry Letters|May 19, 2022
Identification of 2-Pyridinylindole-Based Dual Antagonists of Toll-like Receptors 7 and 8 (TLR7/8)Ratna Kumar Sreekantha, Christopher P Mussari, Dharmpal S Dodd, et al.ACS Medicinal Chemistry Letters|September 18, 2020
Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9)Christopher P Mussari, Dharmpal S Dodd, Ratna Kumar Sreekantha, et al.Pageof 5